Metabolic and mitochondrial myopathies

Current Opinion in Rheumatology

Volumn 11, Issue 6, 1999, Pages 462-467

  Wortmann, Robert L ^a,b  

^a University of Oklahoma Tulsa College of Medicine   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENERGY METABOLISM; HISTOPATHOLOGY; HUMAN; INBORN ERROR OF METABOLISM; LIPID METABOLISM; MITOCHONDRIAL MYOPATHY; MUSCLE FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYNDROME DELINEATION;

EID: 0032703508     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199911000-00003     Document Type: Review

References (31)

1. Engel AG, Franzini-Armstrong C, eds: Myology, edn 2. New York: McGraw Hill, 1994.
2. Lane RJM, ed: Handbook of Muscle Disease. New York: Marcel Dekker, 1996.
3. Wortmann RL, ed. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams and Wilkins, 1999. Most recent comprehensive text with clinical focus.
4. Frick E, Reutter FW, Weder B. McArdle disease: differential diagnosis of creatine kinase increase induced by the exercise test [in German], Schweiz Med Wochenschr 1988, 118:1993-1996.
5. Kleinman DS, Kunze HE: McArdle's disease and acute renal failure [letter]. Nephron 1988, 48:255.
6. Danon MJ, Serenella S, DiMauro S, Vora S. Late-onset muscle phosphofructokinase deficiency. Neurology 1988, 38:956-960.
7. Sivakumar J, Vasconeelos O, Goldfarb L, Dalakas MC. Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuolar, abnormal mitochondria, and an absence of the common exon 5/intron5 junction point mutation. Neurology 1996, 46:1337-1342.
8. Barohn RJ, McVey AL, DiMauro S. Adult acid maltese deficiency. Muscle Nerve 1993, 16:672-676.
9. Ausems MGEM, Lochman P, vanDiggelen OP, et al. A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 1999, 52:851-853.
10. 31P magnetic resonance spectroscopy study. Acta Neurol Scand 1990, 81:499-503.
11. MacLean D, Vissing J, Vissing SF, Haller RG: Oral branched-chain amino acids do not improve exercise capacity in McArdle's disease. Neurology 1998, 51:1456-1459. Discussion of rationale for use of high-protein diet in patients with glycogen storage diseases.
12. Benon RJ, Bartram C, Hopkins P, Toescu V, Gibson H, Phoenix J, Edwards RH: McArdle's disease: molecular genetics and metabolic consequences of the phenotype. Muscle Nerve 1995, 3:S18-S22.
13. Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A. Schonberger LB: Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999, 340:1377-1382. Although this article focuses on Reye syndrome, it also reviews the importance of differentiating Reye'syndrome from inherited enzyme defects in lipid metabolism.
14. Taggart RT, Smail D, Apolito C, Vladutiu GD: Novel mutations associated with carnitine palmitoyltransferase II deficiency. Human Mutation 1999, 13:210-220. Description of newly described defects and review of the literature.
15. Baerlocher KE, Steinmann B, Aguzzi A, Krahenbuhl S, Roe CR, Vianney-Sabam C: Short-chain acyl-CoA dehydrogenase deficiency in a 16-year-old girl with severe muscle wasting and scoliosis. J Inherited Metab Dis 1997, 20:427-431.
16. Ribes A, Rindor E, Garavaglia B, et al: Mild or absent clinical signs in twin sisters with short-chain acyl-CoA dehydrogenase deficiency. Eur J Pediatr 1998, 157:317-320. Reviews spectrum of presentations for this disorder of β-oxidation.
17. Turnbull DM, Shepherd IM, Ashworth B, et al: Lipid storage myopathy associated with low acyl-CoA dehydrogenase activities. Brain 1988, 111:815-828.
18. Zeviani M, Tiranti V, Piantades C: Mitochondrial disorders. Medicine (Baltimore) 1998, 77:59-72. Excellent review of the mitochondrial myopathy.
19. Met gene mutation in a patient with dystrophic muscle and exercise intolerance. Neurology 1998, 50:1875-1878.
20. fysine mitochondrial DNA mutation. Neurology 1998, 51:1447-1450.
21. Andreu AL, Bruno C, Dunne TC, et al: A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol 1999, 45:127-130.
22. Vu TH, Sciacco M, Tanji K, et al: Clinical manifestations of mitochondrial DNA depletion. Neurology 1998, 50:1783-1790.
23. Sciacco M, Gasparo-Rippa P, Vu TH, et al: Study of mitochondrial DNA depletion in muscle by single-fiber polymerase chain reaction. Muscle Nerve 1998, 21:1374-1381.
24. Taanman JW, Bodnar AG, Cooper JM, Morris AA, Clayton PT, Leonard JV, Schapira AH: Molecular mechanisms in mitochondrial DNA depletion syndrome. Hum Mol Genet 1997, 6:935-942.
25. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In The metabolic and molecular bases of inherited disease. Scriver CR, Beaudet AL, Sly WS, Valle D, eds. New York, McGraw-Hill, 1535-1609.
26. Tarnopolsky M, Martin J: Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999, 52:854-857. Therapy worth considering in patients with any metabolic myopathy.
27. Taivassalo T, DeStefano N, Argov Z, Matthews PM, Chen J, Genge A, et al: Effects of aerobic training in patients with mitochondrial myopathies. Neurology 1998, 50:1055-1060. Demonstrates positive effects of exercise training even for individuals with disordered energy metabolism.
28. Elliot DL, Buist NRM, Goldberg L, Kennaway NG, Powell BR, Kuehl KS: Metabolic myopathies: evaluation by graded exercise testing. Medicine (Baltimore) 1989, 68:163-172.
29. Videen JS, Haseler LJ, Karpinski N, Terkeltaub RA: Noninvasive evaluation of adult myopathy form carnitine palmitoyltransferase II (CPT II) deficiency using proton magnetic resonance spectroscopy of muscle. J Rheumatol 1999, 26:1757-1763. This technique may prove useful in screening for CPT deficiency.
30. Fleckenstein JL, Peshosck RM, Lewis SF, Haller RG: Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies. Muscle Nerve 1989, 12:849-855.
31. deJager AEJ, van der Vliet TM, van der Ree TC, Oosterink BJ, Loonen MC: Muscle computed tomography in adult-acid maltase deficiency. Muscle Nerve 1998, 31:398-400.